bpc-157 compounding restrictions fda An advisory committee voted Thursday to remove on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with BREAKING: The FDA just reversed
BREAKING: The FDA just reversed theIR 2023 peptide ban. 12 peptides were just pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu (injectable) BPC 157 FDA Approval Status: Is It Approved for Human Use? The FDA cracked down on BPC 157 and now the biohackers are losing their minds Big win for $HIMS. The FDA advisory panel voted to allow compounding of BPC 157, KPV, TB 500 and MOTS C, opening the door to a multibillion dollar peptide market. Hims is positioned to capitalize.
Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


